Compared to conventional imaging techniques, prostate specific membrane antigen (PSMA) PET imaging provides superior ...
The addition of apalutamide to androgen deprivation therapy before and after surgery improved outcomes among men with ...
Radical prostatectomy is potentially curative in patients with high-risk localized or locally advanced prostate cancer; however, relapse occurs within 5 years in up to 50% of patients. We ...
The 2026 SNMMI annual meeting featured a genitourinary diagnosis and imaging session, including a presentation by Dr. Surekha Yadav discussing longitudinal outcomes of PSMA PET/CT-detected bone ...
Figure 3: Immunohistochemistry (IHC) and Immunofluorescence (IF) analysis of MD2 expression and immune cell infiltration in prostate cancer tissues. (Upper panel) Representative IF images showing ...
SurvivorNet on MSN
ASCO 2026: A major prostate cancer trial shows drug can keep high-risk disease from returning for longer
Data from the PROTEUS trial showed that adding a hormone-blocking pill called apalutamide to standard hormone therapy, both ...
Radium-223 is an α-emitting radiopharmaceutical that improves survival in metastatic castration-resistant prostate cancer (mCRPC). Preclinical data suggest synergy between poly(ADP-ribose) polymerase ...
Former President Joe Biden has been diagnosed with an aggressive form of prostate cancer, with metastasis to the bone, according to a statement from his personal office Sunday. Doctors diagnosed Biden ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results